Cargando…

Diagnostic Value of the International Society of Cardio‐Oncology Definition for Suspected Immune Checkpoint Inhibitor–Associated Myocarditis

Detalles Bibliográficos
Autores principales:	Deharo, Francois, Thuny, Franck, Cadour, Farah, Resseguier, Noemie, Meilhac, Alexandra, Gaubert, Melanie, Dolladille, Charles, Paganelli, Franck, Alexandre, Joachim, Cautela, Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227269/ https://www.ncbi.nlm.nih.gov/pubmed/37042287 http://dx.doi.org/10.1161/JAHA.122.029211

Ejemplares similares

Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis
por: Cautela, Jennifer, et al.
Publicado: (2020)

Management of Immune Checkpoint Inhibitor–Induced Myocarditis: The French Working Group’s Plea for a Pragmatic Approach
por: Thuny, Franck, et al.
Publicado: (2021)

What Is the Evidence of the Diagnostic Criteria and Screening of Immune Checkpoint Inhibitor–Induced Myocarditis?
por: Thuny, Franck, et al.
Publicado: (2022)

High incidence of atrial fibrillation in patients treated with ibrutinib
por: Baptiste, Florian, et al.
Publicado: (2019)

Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines
por: Alexandre, Joachim, et al.
Publicado: (2020)

Correction to: Diagnostic Value of the International Society of Cardio‐Oncology Definition for Suspected Immune Checkpoint Inhibitor–Associated Myocarditis
Publicado: (2023)

New Insights in Early Detection of Anticancer Drug-Related Cardiotoxicity Using Perfusion and Metabolic Imaging
por: Cadour, Farah, et al.
Publicado: (2022)

Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors
por: Dolladille, Charles, et al.
Publicado: (2020)

Wearable cardioverter defibrillator: Bridge or alternative to implantation?
por: Barraud, Jeremie, et al.
Publicado: (2017)

Hypertrophic cardiomyopathy and fibrosis: correlation between late gadolinium enhancement on CMR and speckle tracking imaging using Ultrasound
por: Cautela, Jennifer, et al.
Publicado: (2015)

Immune Checkpoint Inhibitor-Induced Myositis/Myocarditis with Myasthenia Gravis-like Misleading Presentation: A Case Series in Intensive Care Unit
por: Deharo, François, et al.
Publicado: (2022)

Specific Pharmacological Profile of A(2A) Adenosine Receptor Predicts Reduced Fractional Flow Reserve in Patients With Suspected Coronary Artery Disease
por: Paganelli, Franck, et al.
Publicado: (2018)

Etiology and Prognosis of Cardiogenic Shock in a Secondary Center without Surgical Back-Up
por: Bonello, Laurent, et al.
Publicado: (2019)

Diffusion weighted imaging changes in extra-abdominal desmoid tumor after cryotherapy
por: Cadour, Farah, et al.
Publicado: (2023)

Electrocardiographic features of immune checkpoint inhibitor associated myocarditis
por: Zlotoff, Daniel A, et al.
Publicado: (2021)

Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology
por: Liang, Zehua, et al.
Publicado: (2022)

Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
por: Albini, Adriana, et al.
Publicado: (2010)

Cardiac Computed Tomography in Cardio-Oncology: JACC: CardioOncology Primer
por: Lopez-Mattei, Juan C., et al.
Publicado: (2021)

The ESC 2022 Cardio-Oncology Guidelines and the Road Ahead in Cardio-Oncology
por: Cheng, Richard K., et al.
Publicado: (2022)

Cancer Immunotherapy Beyond Checkpoint Blockade: JACC: CardioOncology State-of-the-Art Review
por: Welty, Nathan E., et al.
Publicado: (2022)

Immune checkpoint inhibitors break whose heart? Perspectives from cardio-immuno-oncology
por: He, Yingying, et al.
Publicado: (2023)

Cardio-Oncology in Iran
por: Alizadehasl, Azin, et al.
Publicado: (2021)

Bradyarrhythmias in Cardio-Oncology
por: Fonseca, Marta, et al.
Publicado: (2021)

Cardio-oncology in 2022
por: Dobson, Rebecca
Publicado: (2023)

Adenosine Receptor Reserve and Long-Term Potentiation: Unconventional Adaptive Mechanisms in Cardiovascular Diseases?
por: Guieu, Régis, et al.
Publicado: (2021)

Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field
por: Liu, Victor Y., et al.
Publicado: (2018)

Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors
por: Awadalla, Magid, et al.
Publicado: (2019)

Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: JACC: CardioOncology State-of-the-Art Review
por: Tan, Sean, et al.
Publicado: (2022)

Impact of Platelet Reactivity in ACS Patients on Clinical Outcomes with Triple Antithrombotic Therapy
por: Gruttemeier, Julia, et al.
Publicado: (2021)

Cardio-Oncology Considerations in Oncologic Treatment Decisions
por: Fadol, Anecita P.
Publicado: (2022)

Cardio-oncology: Concepts and practice
por: Cubbon, Richard M., et al.
Publicado: (2016)

New avenues in cardio-oncology
por: Sala, Valentina, et al.
Publicado: (2019)

Hypertension management in cardio-oncology
por: Essa, Hani, et al.
Publicado: (2020)

The Role of Biomarkers in Cardio-Oncology
por: Ananthan, Kajaluxy, et al.
Publicado: (2020)

Cardio-Oncology: Stronger Together
por: Kovacs, Richard J., et al.
Publicado: (2019)

Strain Imaging in Cardio-Oncology
por: Liu, Jennifer E., et al.
Publicado: (2020)

Birth and Maturation of Cardio-Oncology
por: Bhatt, Deepak L.
Publicado: (2019)

My Hope for Cardio-Oncology
por: Ky, Bonnie
Publicado: (2022)

Advancing Cardio-Oncology in Asia
por: Ng, Choon Ta, et al.
Publicado: (2022)

Natriuretic Peptides, Cardio-Oncology…
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kioghap9b09pdov0kl1pb9eluu